Comparative Analysis of Hepatitis B Virus Infections in Blood Donors Born Before and After the I Mplementation of Universal HBV Vaccination in Southern China

Abstract BackgroundNeonatal hepatitis B vaccination program at birth has been implemented nationwide since 1992 in China, which may impact HBV safety in blood donations actively. The true prevalence of HBV, HBsAg, and OBI between vaccinated blood donors and non-vaccinated blood donors should be explored. Study design and methodsThe samples of blood donors were collected and detected for serologic markers of HBV in the Shenzhen Blood Center between Feb 2016 and Jun 2016. The discrepant results were tested with commercial electrochemiluminescence immunoassay (ELCI), alternative MPX ID NAT, nested PCR, sequencing, and a quantitative real-time polymerase chain reaction (PCR) assay. HBsAg and anti-HBs were quantified. The serological and molecular characteristics of HBV infected blood donors were analyzed, and the effects on blood safety for donors born before and after the implementation of universal HBV vaccination were compared. ResultsTotal of 242 reactive by NAT and/or HBsAg ELISA samples from 26318 candidate donors, 192 (0.73%, [95%CI, 0.63-0.84]) HBV+, 131 (0.49%, [95%CI, 0.43-0.59]) HBsAg+, 58 (0.22%, [95%CI,0.17-0.28]) OBI were confirmed respectively. The HBV+ rate in vaccinated donors is lower than in non-vaccinated donors (P<0.05). The HBsAg titers of vaccinated infected blood donors are much higher than non vaccinated infected blood donors. The OBI yield rates in the vaccinated blood donors were 0.11% (7/6422), and significantly lower than 0.26% (51/19898) in the non vaccinated blood donors (P<0.05). 102/124 (82.3%) samples are genotype B, 22/124 (17.7%) are genotype C total. There is no significant difference in the distribution of genotype in the non vaccinated blood donors (B/C,86/17) and the vaccinated blood donors (B/C,23/6) (P>0.05). High frequency of vaccine escape mutation M133L (32.4%) and E164G in S region of genotype B strains and substitution L175S (40.9%) related to vaccine escape in S region of genotype C strains identified.ConclusionThe universal HBV vaccination program markedly reduces the risk of HBV infection in blood donors, and provides a significant guarantee for the safety of blood transfusion. Several important mutations detected related vaccine escape and notable mutations needed further investigated.

Download Full-text

STUDY OF PREVALENCE OF HEPATITIS B SURFACE ANTIGEN (HBSAG) IN BLOOD DONOR POPULATION BORN PRIOR TO AND AFTER IMPLEMENTATION OF HBV VACCINATION IN KERALA, SOUTH INDIA

10.36106/ijar/0405657 ◽

2021 ◽

pp. 66-67

Author(s):

Indu . P.K

Keyword(s):

Hepatitis B ◽

Blood Donor ◽

Blood Donors ◽

Hepatitis B Surface Antigen ◽

Vaccination Schedule ◽

Hbv Infection ◽

Hepatitis B Vaccination ◽

P Value ◽

Hbv Vaccine ◽

Hbv Vaccination

BACKGROUND: Since 1995 Hepatitis B vaccination became a part of Extended immunization Program (EIP) in India, neonates started getting immunoprophylaxis against Hepatitis B virus. Since vaccination started recently, exact prevalence of immunized persons were not available, but anyway vaccinated blood donors over 18 years old are progressively increasing MATERIALS AND METHODS: In this study 2400 blood donors were screened for HBsAg by enzyme linked immunosorbent assays, among the donor blood samples which are positive for HBsAg were noted. Various demographic patterns of blood donor were analyzed. To know about impact of vaccination on prevalence HBV infection among donors who born after the implementation of mandatory HBV vaccination schedule was compared with blood donors those who are born before HBV vaccination schedule RESULTS: Among the blood donors overall prevalence of HBV infection was 0.75% HBsAg. HBV vaccinated blood donor were protected from getting disease ,showing P value of 18 years (0.07), 19 years(0.01), 20 years(0.02) CONCLUSION: Young blood donors born after implementation of universal HBV vaccination in lndia presented higher prevalence of HBsAg but lower incidence of HBsAg seroconversion than older. HBV vaccine boosting for adolescents at 15–17 years old prior to reaching blood donor age may improve blood safety.

Download Full-text

Risk of HBV infection among male and female first-time blood donors born before and after the July 1986 HBV vaccination program in Taiwan

BMC Public Health ◽

10.1186/s12889-021-11846-x ◽

2021 ◽

Vol 21 (1) ◽

Author(s):

Hsuan-Hui Wang ◽

Shu-Lung Sun ◽

Rong-Chiou Jau ◽

Disline Manli Tantoh ◽

Shu-Yi Hsu ◽

...

Keyword(s):

Blood Donors ◽

Blood Donation ◽

Vaccination Program ◽

Birth Date ◽

Birth Cohorts ◽

Male And Female ◽

Hbv Vaccination ◽

Before And After ◽

The Impact ◽

First Time

Abstract Background In July 1984, Taiwan officially began a nationwide hepatitis B virus (HBV) vaccination program where only infants born to HBsAg-positive mothers were vaccinated free of charge until June 1986. However, from July 1986, all infants were vaccinated against HBV. The impact of the July 1986 HBV vaccination program on first-time blood donors has not been exhaustively studied. We, therefore, determined the risk of HBV among male and female first-time blood donors born before and after the July 1986 HBV vaccination program in Taiwan. Methods Initially, we recruited 857,310 first-time blood donors whose data were collected between 2013 and 2018 from 5 blood donation centers in Taiwan. However, we excluded donors with incomplete and outlying data (n = 12,213) and those born between July 1984 and June 1986 (n = 21,054). The final study participants comprised 9118 HBV positive and 814,925 HBV negative individuals. We divided the participants into two birth cohorts (born before and after July 1986) and assumed that those born before July 1986 were not vaccinated at birth while those born after July 1986 were vaccinated. Results The prevalence of HBV among those born before and after July 1986 was 4.53 and 0.25%, respectively. Individuals born after July 1986 had a lower risk of HBV than those born before July 1986. The adjusted odds ratio (OR), 95% confidence interval (CI) was 0.16, 0.13–0.19. Men had a higher risk of HBV than women (OR = 1.40, 95% CI = 1.34–1.47). The interaction between sex and birth date was significant (p-value = 0.0067). Stratification of participants by birth date revealed a higher risk of HBV in men compared to women in both birth cohorts. The OR, 95% CI was 1.47, 1.40–1.55 for those born before July 1986 but declined to 1.15, 1.02–1.29 for those born after July 1986. Conclusions The risk of HBV was lower among those born after than those born before the July 1986 vaccination program. In both cohorts, the risk was high in men relative to women. The seemingly protective effect among those born after July 1986 was higher in women than men.

Download Full-text

Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia

Epidemiology and Infection ◽

10.1017/s0950268816001849 ◽

2016 ◽

Vol 144 (16) ◽

pp. 3365-3375 ◽

Cited By ~ 7

Author(s):

H. CHAOUCH ◽

W. HACHFI ◽

I. FODHA ◽

O. KALLALA ◽

S. SAADI ◽

...

Keyword(s):

Hepatitis B ◽

Geometric Mean ◽

Tunisian Population ◽

Hepatitis B Vaccination ◽

Seroprotection Rate ◽

Positive Hbsag ◽

Hbv Vaccination ◽

Significant Difference ◽

The Impact

SUMMARYHepatitis B virus (HBV) vaccination has been part of the Expanded Programme of Immunization (EPI) in Tunisia since 1995. The aim of this study was to evaluate, for the first time, the impact of mass vaccination in Tunisia 17 years after this programme was implemented, and in parallel, assess the long-term persistence of anti-HBs antibody in the vaccinated Tunisian population. A total of 1422 students were recruited (703 vaccinated, 719 non-vaccinated). HBV seromarkers were checked. None of the students from either group had positive HBsAg. The overall prevalence of anti-HBc was 0·8%. A Significantly higher prevalence of anti-HBc was noted in unvaccinated students than in vaccinated (1·4% vs. 0·3%, P = 0·02). The overall seroprotection rate (anti-HBs titre ⩾10 mIU/ml) was 68·9% in vaccinated subjects. Seroprotection rates and geometric mean titres decreased significantly with increasing age, reflecting waning anti-HBs titre over time. No significant difference was detected between seroprotection rates and gender or students’ area of origin. Incomplete vaccination was the only factor associated with an anti-HBs titre <10 mIU/ml. This study demonstrates the excellent efficacy of the HBV vaccination programme in Tunisia 17 years after its launch. However, a significant decline of anti-HBs seroprotection has been observed in ⩾15-year-old adolescents which places them at risk of infection. Additional studies are needed in hyperendemic regions in Tunisia.

Download Full-text

Compliance with a hepatitis B vaccination program

Journal of Dental Education ◽

10.1002/j.0022-0337.1984.48.10.tb01830.x ◽

1984 ◽

Vol 48 (10) ◽

pp. 563-565

Author(s):

HJ Kwon ◽

KM Keenan ◽

H Colman ◽

KM Sundeen ◽

DE Waite

Keyword(s):

Hepatitis B ◽

Vaccination Program ◽

Hepatitis B Vaccination

Download Full-text

Compliance with a voluntary hepatitis B vaccination program

Journal of Dental Education ◽

10.1002/j.0022-0337.1988.52.2.tb02174.x ◽

1988 ◽

Vol 52 (2) ◽

pp. 118-120

Author(s):

TK Rowe ◽

CW Douglass

Keyword(s):

Hepatitis B ◽

Vaccination Program ◽

Hepatitis B Vaccination

Download Full-text

Hepatitis B Vaccination in Senegalese Children: Coverage, Timeliness, and Sociodemographic Determinants of Non-Adherence to Immunisation Schedules (ANRS 12356 AmBASS Survey)

Vaccines ◽

10.3390/vaccines9050510 ◽

2021 ◽

Vol 9 (5) ◽

pp. 510

Author(s):

Lauren Périères ◽

Fabienne Marcellin ◽

Gora Lo ◽

Camelia Protopopescu ◽

El Ba ◽

...

Keyword(s):

Hepatitis B ◽

Dose Schedule ◽

World Health Organisation ◽

Sub Saharan Africa ◽

World Health ◽

Hepatitis B Vaccination ◽

Detailed Knowledge ◽

Cross Sectional Survey ◽

Cross Sectional ◽

Hbv Vaccination

Detailed knowledge about hepatitis B virus (HBV) vaccination coverage and timeliness for sub-Saharan Africa is scarce. We used data from a community-based cross-sectional survey conducted in 2018–2019 in the area of Niakhar, Senegal, to estimate coverage, timeliness, and factors associated with non-adherence to the World Health Organisation-recommended vaccination schedules in children born in 2016 (year of the birth dose (BD) introduction in Senegal) and 2017–2018. Vaccination status was assessed from vaccination cards, surveillance data, and healthcare post vaccination records. Among 241 children with available data, for 2016 and 2017–2018, respectively, 31.0% and 66.8% received the BD within 24 h of birth (BD schedule), and 24.3% and 53.7% received the BD plus at least two pentavalent vaccine doses within the recommended timeframes (three-dose schedule). In logistic regression models, home birth, dry season birth, and birth in 2016 were all associated with non-adherence to the recommended BD and three-dose schedules. Living over three kilometres from the nearest healthcare post, being the firstborn, and living in an agriculturally poorer household were only associated with non-adherence to the three-dose schedule. The substantial proportion of children not vaccinated according to recommended schedules highlights the importance of considering vaccination timeliness when evaluating vaccination programme effectiveness. Outreach vaccination activities and incentives to bring children born at home to healthcare facilities within 24 h of birth, must be strengthened to improve timely HBV vaccination.

Download Full-text

Implementing a Successful Hepatitis B Vaccination Program

Infection Control ◽

10.1017/s0195941700063153 ◽

1985 ◽

Vol 6 (8) ◽

pp. 306-309 ◽

Cited By ~ 7

Author(s):

Linda J. Hanacik ◽

Timothy R. Franson ◽

Jill D. Gollup ◽

Michael W. Rytel

Keyword(s):

High Risk ◽

Hepatitis B ◽

Administrative Support ◽

Health Benefit ◽

Vaccine Safety ◽

Vaccination Program ◽

Hepatitis B Vaccination ◽

Vaccination Programs ◽

B Virus ◽

Key Steps

AbstractHealth care personnel with frequent blood contact are at high risk for being exposed to and developing hepatitis B infection. Exposure to unidentified infectious patients may lead to personnel inadvertently foregoing appropriate, passive immunoprophylaxis. For these reasons, our hospital elected to conduct an aggressive program to administer hepatitis B vaccine to all employees at high risk for exposure to hepatitis B virus, thus protecting such employees from inadvertent occupational exposure. Administrators agreed to offer the vaccine as a free employee health benefit. “High-risk” employees attended mandatory inservice presentations covering hepatitis B disease, vaccine safety and efficacy, and related concerns. High-risk individuals were required to either receive vaccine or sign “informed refusal” forms. The vaccine clinic was organized to accommodate employee work schedules. Of high-risk employees eligible for vaccination, 90% completed a three-dose vaccine course. Extensive inservice education, financial and administrative support, and careful advance planning are all crucial in achieving high compliance with vaccination programs. A description of key steps in designing a successful vaccination program is outlined.

Download Full-text